Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01223872 · ClinicalTrials.gov registry record
Childhood Cancer Survivors' Knowledge of Diagnosis,Treatment and Risk of Late Effects: Specialized Survivorship Clinic
A clinical trial of Childhood Cancer, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 188
- Enrollment target
- 1
- Study location
NCT01223872 is a study of Childhood Cancer that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 188 participants, below the 1,464-participant average among 23 other Childhood Cancer trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01223872, a study of Childhood Cancer, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 188 participants
- Enrollment target
- 1
- Study location
Study Summary
This two-part research study will compare childhood cancer survivors receiving specialized follow-up care in the REACH for Survivorship clinic to patients receiving routine follow-up care.
Conditions Studied
Interventions
- OTHER interview
- OTHER clinic visit and interview
- OTHER interviews and clinic visit
Study Locations (1)
Tennessee
- Vanderbilt-Ingram Cancer Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2010-08 |
| Est. Completion | 2015-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01223872
The ClinicalTrials.gov registry entry for NCT01223872 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 188 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,464-participant average among 23 other Childhood Cancer trials with a reported enrollment target (87% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Childhood Cancer appearing as the primary indexed condition, and to 3 interventions - of which interview is the first listed.
NCT01223872 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT01223872 about?
NCT01223872 is a clinical study titled "Childhood Cancer Survivors' Knowledge of Diagnosis,Treatment and Risk of Late Effects: Specialized Survivorship Clinic". This two-part research study will compare childhood cancer survivors receiving specialized follow-up care in the REACH for Survivorship clinic to patients receiving routine follow-up care.
What is the current status of trial NCT01223872?
This trial is currently completed. The enrollment target is 188 participants. The study started on 2010-08. Estimated completion is 2015-08.
What conditions does trial NCT01223872 study?
This clinical trial studies the following conditions: Childhood Cancer.
What interventions are being tested in trial NCT01223872?
The interventions under investigation include: interview (OTHER), clinic visit and interview (OTHER), interviews and clinic visit (OTHER).
Who is sponsoring clinical trial NCT01223872?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01223872 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Childhood Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Preparing for Life and Academics for Young Childhood Cancer Survivors
RECRUITING · NA
-
Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma
RECRUITING · NA
-
Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors
RECRUITING · NA
-
Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors
RECRUITING · NA
-
Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care
RECRUITING · NA
-
Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Survivors
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.